These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1534438)

  • 1. Picture of the month. Tay-Sachs disease.
    Arisoy AE; Ozden S; Arisoy ES; Kocabay K; Guvenc H; Tunnessen WW
    Am J Dis Child; 1992 Jun; 146(6):767-8. PubMed ID: 1534438
    [No Abstract]   [Full Text] [Related]  

  • 2. Population-based carrier screening and prenatal diagnosis.
    Strom CM
    MLO Med Lab Obs; 2004 Aug; 36(8):12-7; quiz 20-1. PubMed ID: 15366363
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical Issues with Genetic Testing for Tay-Sachs.
    Clayton T
    J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tay-Sachs disease: a case report].
    Koch S; Widhalm K
    Padiatr Padol; 1991; 26(6):275-8. PubMed ID: 1838805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cherry red spot macula in the context of Tay-Sachs disease].
    Zarrouki M; El Yadari M; Azennoud S; Harchali S; El Merrouni S; Bengarai W; Belaydi W; Hajji Z; Boulanouar A; Berraho A
    J Fr Ophtalmol; 2017 Nov; 40(9):805-806. PubMed ID: 29029825
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular basis of Tay-Sachs disease: mutation identification and diagnosis.
    Mahuran DJ; Triggs-Raine BL; Feigenbaum AJ; Gravel RA
    Clin Biochem; 1990 Oct; 23(5):409-15. PubMed ID: 2147596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.
    Brillante R; Yang V; Proos A; Burnett L
    Clin Chem; 1995 Feb; 41(2):321-2. PubMed ID: 7874790
    [No Abstract]   [Full Text] [Related]  

  • 11. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
    Landels EC; Ellis IH; Bobrow M; Fensom AH
    J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis.
    Navon R; Adam A
    Am J Hum Genet; 1985 Sep; 37(5):1031-3. PubMed ID: 2931975
    [No Abstract]   [Full Text] [Related]  

  • 13. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
    Kaplan F
    Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystonia in GM2 gangliosidosis.
    Hardie RJ; Morgan-Hughes JA
    Mov Disord; 1992 Oct; 7(4):390-1. PubMed ID: 1484544
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease.
    Stockley TL; Ray PN
    Methods Mol Biol; 2003; 217():131-41. PubMed ID: 12491928
    [No Abstract]   [Full Text] [Related]  

  • 16. Tay-Sachs disease screening and diagnosis: evolving technologies.
    Hechtman P; Kaplan F
    DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease.
    Ekstein J; Katzenstein H
    Adv Genet; 2001; 44():297-310. PubMed ID: 11596991
    [No Abstract]   [Full Text] [Related]  

  • 18. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
    Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
    JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
    Peleg L; Gazit E; Goldman B; Akstein E
    Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
    Colaianni A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.